WO2003070690A3 - Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Download PDF

Info

Publication number
WO2003070690A3
WO2003070690A3 PCT/FR2003/000506 FR0300506W WO03070690A3 WO 2003070690 A3 WO2003070690 A3 WO 2003070690A3 FR 0300506 W FR0300506 W FR 0300506W WO 03070690 A3 WO03070690 A3 WO 03070690A3
Authority
WO
WIPO (PCT)
Prior art keywords
optionally substituted
derivative
production
amino acid
pharmaceutical compositions
Prior art date
Application number
PCT/FR2003/000506
Other languages
English (en)
Other versions
WO2003070690A2 (fr
Inventor
Nanteuil Guillaume De
Philippe Gloanec
Tony Verbeuren
Alain Rupin
Original Assignee
Servier Lab
Nanteuil Guillaume De
Philippe Gloanec
Tony Verbeuren
Alain Rupin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to UA20040907682A priority Critical patent/UA77763C2/uk
Priority to CA002474785A priority patent/CA2474785A1/fr
Priority to MXPA04007988A priority patent/MXPA04007988A/es
Priority to EP03720618A priority patent/EP1476421A2/fr
Application filed by Servier Lab, Nanteuil Guillaume De, Philippe Gloanec, Tony Verbeuren, Alain Rupin filed Critical Servier Lab
Priority to JP2003569599A priority patent/JP4106337B2/ja
Priority to KR1020047013041A priority patent/KR100668194B1/ko
Priority to NZ534359A priority patent/NZ534359A/en
Priority to AU2003224198A priority patent/AU2003224198A1/en
Priority to BR0307776-4A priority patent/BR0307776A/pt
Priority to US10/505,005 priority patent/US7265220B2/en
Priority to EA200401011A priority patent/EA006389B1/ru
Publication of WO2003070690A2 publication Critical patent/WO2003070690A2/fr
Publication of WO2003070690A3 publication Critical patent/WO2003070690A3/fr
Priority to NO20043910A priority patent/NO20043910L/no
Priority to HK05111846A priority patent/HK1079764A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/10—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/14—Benz[f]indenes; Hydrogenated benz[f]indenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/28—Phenalenes; Hydrogenated phenalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Composé de formule (I) : dans laquelle : R1 représente un groupement aryle, hétéroaryle, alkyle éventuellement substitué, ou un groupement de formule -(CO)-CR6R7NR8R9 dans lequel R6, R7, R8 et R9 sont tels que définis dans la description, R2 représente un atome d'hydrogène ou un groupement alkyle, R3 représente un atome d'hydrogène ou un groupement alkyle éventuellement substitué, R4 représente un atome d'hydrogène ou un groupement alkyle éventuellement substitué, ou bien R3 et R4 forment ensemble, avec l'atome de carbone qui les porte, un système mono-, bi- ou tricyclique, saturé ou insaturé, de 3 à 18 chaînons, comportant éventuellement un ou plusieurs hétéroatomes choisis parmi O, S et N, et éventuellement substitué, n représente zéro, 1 ou 2, Ar représente un groupement aryle ou hétéroaryle, R5 représente un groupement amino, guanidino, cyano ou amidino éventuellement substitué, ses isomères optiques ainsi que ses sels d'addition à un acide pharmaceutiquement acceptable.
PCT/FR2003/000506 2002-02-21 2003-02-17 Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent WO2003070690A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
KR1020047013041A KR100668194B1 (ko) 2002-02-21 2003-02-17 아미노산 유도체, 이의 제조 방법 및 이를 포함하는 약제조성물
MXPA04007988A MXPA04007988A (es) 2002-02-21 2003-02-17 Nuevos derivados de aminoacidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EP03720618A EP1476421A2 (fr) 2002-02-21 2003-02-17 Nouveaux derives d acides amines, leur procede de preparatio n et les compositions pharmaceutiques qui les contiennent
AU2003224198A AU2003224198A1 (en) 2002-02-21 2003-02-17 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
JP2003569599A JP4106337B2 (ja) 2002-02-21 2003-02-17 新規なアミノ酸誘導体、その製造方法及び該誘導体を含む薬剤組成物
CA002474785A CA2474785A1 (fr) 2002-02-21 2003-02-17 Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NZ534359A NZ534359A (en) 2002-02-21 2003-02-17 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
UA20040907682A UA77763C2 (en) 2002-02-21 2003-02-17 Amino acids derivatives, a process for preparation thereof and pharmaceutical composition containing them
BR0307776-4A BR0307776A (pt) 2002-02-21 2003-02-17 Derivados de ácidos aminados, o respectivo processo de preparo e as composições farmacêuticas que os contêm
US10/505,005 US7265220B2 (en) 2002-02-21 2003-02-17 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
EA200401011A EA006389B1 (ru) 2002-02-21 2003-02-17 Новые соединения аминокислоты, способ их получения и фармацевтические композиции, содержащие их
NO20043910A NO20043910L (no) 2002-02-21 2004-09-20 Nye aminosyreforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
HK05111846A HK1079764A1 (en) 2002-02-21 2005-12-22 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0202199A FR2836143B1 (fr) 2002-02-21 2002-02-21 Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR02/02199 2002-02-21

Publications (2)

Publication Number Publication Date
WO2003070690A2 WO2003070690A2 (fr) 2003-08-28
WO2003070690A3 true WO2003070690A3 (fr) 2004-04-08

Family

ID=27636380

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/000506 WO2003070690A2 (fr) 2002-02-21 2003-02-17 Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (21)

Country Link
US (1) US7265220B2 (fr)
EP (1) EP1476421A2 (fr)
JP (1) JP4106337B2 (fr)
KR (1) KR100668194B1 (fr)
CN (1) CN1257889C (fr)
AR (1) AR038443A1 (fr)
AU (1) AU2003224198A1 (fr)
BR (1) BR0307776A (fr)
CA (1) CA2474785A1 (fr)
EA (1) EA006389B1 (fr)
FR (1) FR2836143B1 (fr)
GE (1) GEP20074100B (fr)
HK (1) HK1079764A1 (fr)
MA (1) MA27110A1 (fr)
MX (1) MXPA04007988A (fr)
NO (1) NO20043910L (fr)
NZ (1) NZ534359A (fr)
PL (1) PL370817A1 (fr)
UA (1) UA77763C2 (fr)
WO (1) WO2003070690A2 (fr)
ZA (1) ZA200406027B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
GB0807828D0 (en) * 2008-04-29 2008-06-04 Vantia Ltd Aminopyridine derivatives
US9290485B2 (en) * 2010-08-04 2016-03-22 Novartis Ag N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
GB201322091D0 (en) 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
US11666888B2 (en) 2018-02-05 2023-06-06 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
AU2019371209A1 (en) * 2018-10-29 2021-05-27 Huahai Us Inc Novel dipeptide compounds and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022125A1 (fr) * 1996-11-19 1998-05-28 Saulius Butenas Peptidomimetiques contenant des fractions de 6-peptidylamino-1-naphtalenesulfonamide
EP1078917A1 (fr) * 1998-02-17 2001-02-28 Ono Pharmaceutical Co., Ltd. Derives amidino utilises comme ingredients actifs et medicaments les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1078204C (zh) * 1993-04-28 2002-01-23 久美蓝化学工业株式会社 氨基酸酰胺衍生物及其杀真菌的用途和制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022125A1 (fr) * 1996-11-19 1998-05-28 Saulius Butenas Peptidomimetiques contenant des fractions de 6-peptidylamino-1-naphtalenesulfonamide
EP1078917A1 (fr) * 1998-02-17 2001-02-28 Ono Pharmaceutical Co., Ltd. Derives amidino utilises comme ingredients actifs et medicaments les contenant

Also Published As

Publication number Publication date
CN1633412A (zh) 2005-06-29
JP2005517734A (ja) 2005-06-16
FR2836143B1 (fr) 2004-04-16
UA77763C2 (en) 2007-01-15
EA006389B1 (ru) 2005-12-29
MXPA04007988A (es) 2004-11-26
CA2474785A1 (fr) 2003-08-28
WO2003070690A2 (fr) 2003-08-28
US20050085517A1 (en) 2005-04-21
NZ534359A (en) 2005-12-23
AR038443A1 (es) 2005-01-12
EP1476421A2 (fr) 2004-11-17
ZA200406027B (en) 2006-06-28
KR20040085219A (ko) 2004-10-07
HK1079764A1 (en) 2006-04-13
PL370817A1 (en) 2005-05-30
CN1257889C (zh) 2006-05-31
FR2836143A1 (fr) 2003-08-22
BR0307776A (pt) 2004-12-07
MA27110A1 (fr) 2004-12-20
JP4106337B2 (ja) 2008-06-25
US7265220B2 (en) 2007-09-04
KR100668194B1 (ko) 2007-01-11
AU2003224198A1 (en) 2003-09-09
NO20043910L (no) 2004-09-20
EA200401011A1 (ru) 2004-12-30
GEP20074100B (en) 2007-05-10

Similar Documents

Publication Publication Date Title
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
ATE229017T1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
CA2510853A1 (fr) Derives de pyrrolopyrimidine
ATE139232T1 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
NZ536734A (en) Spiroindolinepiperidine derivatives
WO2004058679A3 (fr) Ligands d'adenine nucleotide translocase (ant) et compositions et methodes associees
WO2006042954A8 (fr) Dérivés de 2-amido-4-phenylthiazole, leur préparation et leur application en thérapeutique
DE602005018972D1 (de) 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren
WO2004014868A8 (fr) Derives de pyrimidine 2,4-diones, utilises comme inhibiteurs de metalloproteinase matricielle
CA2124455A1 (fr) Derives indole, methode de production et utilisation en medecine
HUP0300370A2 (hu) Antimikrobiális hatású 2-hidroxi-mutilin-karbamát-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
WO2003070690A3 (fr) Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
BR0010225A (pt) Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
WO2004058683A3 (fr) Ligands d'adenine nucleotide translocase (ant) et compositions et methodes associees
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
DE60234024D1 (de) Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
RU94032285A (ru) Цефалоспориновые соединения, способ их получения, фармацевтическая композиция
EP1571144A4 (fr) Compose diamine cyclique hydroxyalkyle
WO2004048381A3 (fr) Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques
ATE307809T1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
EA200000374A3 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004/06027

Country of ref document: ZA

Ref document number: 200406027

Country of ref document: ZA

Ref document number: 534359

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2003720618

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2474785

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/007988

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 20038041189

Country of ref document: CN

Ref document number: 10505005

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003224198

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020047013041

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2003569599

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 200401011

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 8409

Country of ref document: GE

WWP Wipo information: published in national office

Ref document number: 1020047013041

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003720618

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 534359

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 534359

Country of ref document: NZ